North America Clot Management Devices Market (2016 - 2022)
North America captures maximum share of the Clot Management Devices market with the high acceptance of technologically advanced products coupled with higher awareness among the customers. As per the World Health Organisation (WHO), more than 17 million people die annually from cardiovascular diseases. The main reason for cardiovascular diseases are increasing consumption of tobacco products, physical inactivity, changes in diet plans, air pollution and work pressure. Blood Clotting also known as coagulation is the body’s response to an injury to prevent bleeding. However, a clot can be harmful when it forms abnormal flows through the vessels. The excessive formation of clots in the blood leads to different diseases such as brain stroke, heart attack and severe leg pain. Blood Clot forms in one or more veins located deep inside a human body would lead to Deep Vein Thrombosis (DVT) and could damage an organ completely. Clot Management devices are used for the treatment of coronary thrombosis, periphery artery, arteriovenous, neurovascular and DVT.
Based on the product type, the Clot Management Devices market is segmented into Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) devices, Neurovascular Embolectomy Devices and Inferior vena cava filters. Based on End user Type, the market is segmented into Hospitals and Diagnostic Centres.
Based on Country, North America Clot Management Devices market is segmented into US, Canada, Mexico and Rest of North America. US remained the dominant Country in the North America Clot Management Devices market in 2015. Canada would witness promising CAGR during the forecast period (2016-2022).
The report covers the analysis of key stake holders of the Clot Management Devices market. Key companies profiled in the report include Teleflex Inc., Edwards Lifesciences Corporation, Medtronic Plc, Boston Scientific Corporation, Lemaitre Vascular, Inc., Straub Medical AG, Cook Medical Inc. and Johnson & Johnson.